A Safety Study Assessing the Effects of Receiving Genome Sequencing Results

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
History of Cancer
Interventions
BEHAVIORAL

qualitative interviews

A week before the participants return to the clinic to learn of their results, the RSA will call each participant to complete the Hospital Anxiety \& Depression Scale (HADS), revised Impact of Events Scale (IES-R), \& a questionnaire about their health behaviors, to establish baseline distress levels \& health behaviors. A week later, participants will return to the Clinical Genetics Service to review their results with the genetics provider \& discuss resultant therapeutic \& management recommendations for the participants \& their relatives. A week later, the RSA will call each participant to complete the HADS, IES-R again, to establish the safety of receiving these results. Participants will also be asked to complete the revised Multidimensional Impact of Cancer Risk Assessment (MICRA) measure. The RSA will also invite participants to complete an in-depth telephone interview.

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01692223 - A Safety Study Assessing the Effects of Receiving Genome Sequencing Results | Biotech Hunter | Biotech Hunter